ID   E2AKA_CAEEL             Reviewed;        1077 AA.
AC   Q19192; Q20458;
DT   26-SEP-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1998, sequence version 2.
DT   18-JUN-2025, entry version 189.
DE   RecName: Full=Eukaryotic translation initiation factor 2-alpha kinase pek-1 {ECO:0000305|PubMed:10677345};
DE            EC=2.7.11.1 {ECO:0000269|PubMed:10677345};
DE   AltName: Full=CePEK;
DE            Short=PEK;
DE   AltName: Full=PRKR-like endoplasmic reticulum kinase;
DE            Short=PERK;
DE   Flags: Precursor;
GN   Name=pek-1; ORFNames=F46C3.1;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditina; Rhabditomorpha; Rhabditoidea; Rhabditidae; Peloderinae;
OC   Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, CATALYTIC ACTIVITY, AND INDUCTION.
RX   PubMed=10677345; DOI=10.1042/bj3460281;
RA   Sood R., Porter A.C., Ma K., Quilliam L.A., Wek R.C.;
RT   "Pancreatic eukaryotic initiation factor-2alpha kinase (PEK) homologues in
RT   humans, Drosophila melanogaster and Caenorhabditis elegans that mediate
RT   translational control in response to endoplasmic reticulum stress.";
RL   Biochem. J. 346:281-293(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, AND DISRUPTION
RP   PHENOTYPE.
RX   PubMed=11779465; DOI=10.1016/s0092-8674(01)00612-2;
RA   Shen X., Ellis R.E., Lee K., Liu C.-Y., Yang K., Solomon A., Yoshida H.,
RA   Morimoto R., Kurnit D.M., Mori K., Kaufman R.J.;
RT   "Complementary signaling pathways regulate the unfolded protein response
RT   and are required for C. elegans development.";
RL   Cell 107:893-903(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for investigating
RT   biology.";
RL   Science 282:2012-2018(1998).
RN   [4]
RP   FUNCTION.
RX   PubMed=16184190; DOI=10.1371/journal.pgen.0010037;
RA   Shen X., Ellis R.E., Sakaki K., Kaufman R.J.;
RT   "Genetic interactions due to constitutive and inducible gene regulation
RT   mediated by the unfolded protein response in C. elegans.";
RL   PLoS Genet. 1:e37-e37(2005).
RN   [5]
RP   FUNCTION.
RX   PubMed=20733002; DOI=10.1128/mcb.00922-10;
RA   Mao X.R., Crowder C.M.;
RT   "Protein misfolding induces hypoxic preconditioning via a subset of the
RT   unfolded protein response machinery.";
RL   Mol. Cell. Biol. 30:5033-5042(2010).
CC   -!- FUNCTION: Phosphorylates the alpha subunit of eukaryotic translation-
CC       initiation factor 2 (eIF2alpha), leading to its inactivation and thus
CC       to a rapid reduction of translational initiation and repression of
CC       global protein synthesis (PubMed:10677345). May phosphorylate eIF2alpha
CC       during hypoxia (PubMed:20733002). Proposed to have a role in
CC       alleviating endoplasmic reticulum stress (PubMed:10677345,
CC       PubMed:11779465, PubMed:16184190). {ECO:0000269|PubMed:10677345,
CC       ECO:0000269|PubMed:11779465, ECO:0000303|PubMed:20733002}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP +
CC         H(+); Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000269|PubMed:10677345};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] +
CC         ADP + H(+); Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-
CC         COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000269|PubMed:10677345};
CC   -!- ACTIVITY REGULATION: Perturbation in protein folding in the endoplasmic
CC       reticulum (ER) promotes reversible dissociation from HSPA5/BIP and
CC       oligomerization, resulting in transautophosphorylation and kinase
CC       activity induction (By similarity). {ECO:0000250|UniProtKB:Q9Z2B5}.
CC   -!- SUBUNIT: Forms dimers with HSPA5/BIP in resting cells. Oligomerizes in
CC       ER-stressed cells (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250};
CC       Single-pass type I membrane protein {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Expressed in intestinal cells.
CC       {ECO:0000269|PubMed:11779465}.
CC   -!- INDUCTION: By ER stress. {ECO:0000269|PubMed:10677345}.
CC   -!- DOMAIN: The lumenal domain senses perturbations in protein folding in
CC       the ER, probably through reversible interaction with HSPA5/BIP.
CC       {ECO:0000250}.
CC   -!- PTM: Autophosphorylated. {ECO:0000250}.
CC   -!- PTM: N-glycosylated. {ECO:0000250}.
CC   -!- DISRUPTION PHENOTYPE: After L2 growth stage movement is subdued and
CC       development is stunted. Increased sensitivity to tunicamycin which
CC       induces an unfolded protein response symptomatic of endoplasmic
CC       reticulum stress. {ECO:0000269|PubMed:11779465}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr protein
CC       kinase family. GCN2 subfamily. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF193341; AAF61201.1; -; mRNA.
DR   EMBL; AF435953; AAL30829.1; -; mRNA.
DR   EMBL; Z66563; CAA91470.1; -; Genomic_DNA.
DR   EMBL; Z68104; CAA91470.1; JOINED; Genomic_DNA.
DR   PIR; T20579; T20579.
DR   RefSeq; NP_509912.1; NM_077511.8.
DR   AlphaFoldDB; Q19192; -.
DR   SMR; Q19192; -.
DR   FunCoup; Q19192; 2247.
DR   STRING; 6239.F46C3.1.1; -.
DR   GlyCosmos; Q19192; 1 site, No reported glycans.
DR   PaxDb; 6239-F46C3.1; -.
DR   PeptideAtlas; Q19192; -.
DR   EnsemblMetazoa; F46C3.1.1; F46C3.1.1; WBGene00003970.
DR   GeneID; 181334; -.
DR   KEGG; cel:CELE_F46C3.1; -.
DR   UCSC; F46C3.1; c. elegans.
DR   AGR; WB:WBGene00003970; -.
DR   CTD; 181334; -.
DR   WormBase; F46C3.1; CE18695; WBGene00003970; pek-1.
DR   eggNOG; KOG1033; Eukaryota.
DR   GeneTree; ENSGT00940000163863; -.
DR   HOGENOM; CLU_009091_0_0_1; -.
DR   InParanoid; Q19192; -.
DR   OMA; HIVSVWQ; -.
DR   OrthoDB; 5864419at2759; -.
DR   PhylomeDB; Q19192; -.
DR   Reactome; R-CEL-1169408; ISG15 antiviral mechanism.
DR   Reactome; R-CEL-381042; PERK regulates gene expression.
DR   Reactome; R-CEL-9833482; PKR-mediated signaling.
DR   PRO; PR:Q19192; -.
DR   Proteomes; UP000001940; Chromosome X.
DR   Bgee; WBGene00003970; Expressed in embryo and 4 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; ISS:WormBase.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004694; F:eukaryotic translation initiation factor 2alpha kinase activity; IDA:WormBase.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0030968; P:endoplasmic reticulum unfolded protein response; IMP:UniProtKB.
DR   GO; GO:0010629; P:negative regulation of gene expression; IMP:UniProtKB.
DR   GO; GO:0017148; P:negative regulation of translation; IBA:GO_Central.
DR   GO; GO:0045947; P:negative regulation of translational initiation; IC:WormBase.
DR   GO; GO:0002119; P:nematode larval development; IGI:WormBase.
DR   GO; GO:0036499; P:PERK-mediated unfolded protein response; IMP:WormBase.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; IMP:UniProtKB.
DR   GO; GO:0006446; P:regulation of translational initiation; IBA:GO_Central.
DR   GO; GO:0035966; P:response to topologically incorrect protein; IMP:WormBase.
DR   CDD; cd14048; STKc_EIF2AK3_PERK; 1.
DR   FunFam; 2.130.10.10:FF:003372; Eukaryotic translation initiation factor 2-alpha kinase pek-1; 1.
DR   FunFam; 3.30.200.20:FF:000895; Transmembrane ion channel; 1.
DR   Gene3D; 3.30.200.20; Phosphorylase Kinase, domain 1; 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   Gene3D; 2.130.10.10; YVTN repeat-like/Quinoprotein amine dehydrogenase; 1.
DR   InterPro; IPR050339; CC_SR_Kinase.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR018391; PQQ_b-propeller_rpt.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR011047; Quinoprotein_ADH-like_sf.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
DR   PANTHER; PTHR11042:SF91; EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE; 1.
DR   PANTHER; PTHR11042; EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE EIF2-ALPHA KINASE -RELATED; 1.
DR   Pfam; PF00069; Pkinase; 2.
DR   SMART; SM00564; PQQ; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   SUPFAM; SSF50998; Quinoprotein alcohol dehydrogenase-like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Endoplasmic reticulum; Glycoprotein; Kinase; Membrane;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Signal; Stress response; Transferase;
KW   Translation regulation; Transmembrane; Transmembrane helix;
KW   Unfolded protein response.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000255"
FT   CHAIN           24..1077
FT                   /note="Eukaryotic translation initiation factor 2-alpha
FT                   kinase pek-1"
FT                   /id="PRO_0000024325"
FT   TOPO_DOM        24..453
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        454..474
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        475..1077
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          604..1076
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          727..834
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        732..746
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        766..778
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        783..796
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        797..808
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        933
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         610..618
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         633
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   CARBOHYD        206
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
SQ   SEQUENCE   1077 AA;  119639 MW;  DA15615994FC36EC CRC64;
     MSVYYIVLAG FLLFMALVPF NAGQQYIDDD IEVVSSCQNG YVQNAGCDQN SQVNIIITAT
     LDGVVTALDG ETGEMIWRYE DAPLLRGTLS TSDPIDIGGT SLQLMPTLDG RLFSYTHNTN
     LIEPLPITTD SLLESTIRLG QDAVAGGKSV TTKGFDLFTG EQKYECSMES CGPGDTETPK
     NPIILIRRTT NSIRAMDTLR GIERWNLSTA EIGVTLAGGI TSPTLVSDVK ILLQPPDGVI
     VAVDKYNREE WKTNVDGHIV SVWQVYGNQI GEISIFDPSN IFTTQYEVMQ REQHNLQTQS
     SLLYMGTSNG FPFIIQSPKA KNNLKQRMNA LPELSTMTEL TNPRFCTANE ETRSLAYNVK
     DETLRLVLHN AFRHSQSKAI EDKSLSGSSA RRKLQIIASD TEVSAQRIGT ENLRSTSVSK
     SGDYGYLVLE SEPQRVKFKV NSPITLMQTI FSYIFNPTAV VSFLAGLIGV TVAVVYNKIA
     KSSPRMIEHL SSTESAETES ASHRTRTTSF APTDDEIERF VEEGSDLSTT PIGAIHRKPL
     MPIEKSNIET HTQPQIKPVQ RLVKTDIDTD EDSFSNDEKK RLLRNRTISR SSLEGFTSRF
     ANEFEVKKVI GHGGFGVVFR AQSITDMNEY AVKRIAVADN DKARNRVLRE ARALAMFDHP
     GIIRYFYAWE ERPPKGFQEK EDENLLGKIK AEKLAKLHEI KKAKKHTSEG KRVRSADTAS
     FAESFAMPPV VGNTTDAENS WSTSAKPQEV GAKRTTSESK LGLHGGSDRT TAELKEESVA
     FSESDEESDT TEDSSSSDES PSSSSGSSID DEPKKYNSSS GGIEFVDGSD DVDNEAVKET
     KKEIAVIEEL SIHNRAMIVE TENQELEVRE RNDTGDCAYL YIVMQLCAEK TLEDWIRRSK
     TMESRPLFTM KNWIKQLASG LEYLHNKGFI HRDLKPGNVF FSLDSTHGHQ ILKIGDLGLA
     TKTDGAPKIT VRQDSDSSAK HTKNVGTRSY MSPEQLKHQQ YTEKVDIFAL GLVATELIIS
     FSTASERIHT FADFQKGDIP AILDNVPESR DFLLQLTSLE PSERPTAHEV ATHKFLQ
//
